"Congestive Heart Failure" is a wonderful example of a paper on the cardiovascular system. Beta-blockers have been and continue to be the medication of choice in the treatment of congestive heart failure (CHF). Numerous studies have continued to examine the effectiveness of beta-blockers not only in the case of CHF but also as a continuing therapy in the prevention of CHF and as a way of reducing the rate and frequency of admissions for CHF (Panja et al. , 2009). The proposed solution to CHF that is presented here is the use of beta-blockers in addition to appropriate lifestyle changes as a way of reducing health facility visits as well as emergency admissions due to CHF.
The use of beta-blockers in the alleviation of CHF as well as the reduction of the possibility of an emergency need for admission due to CHF or hypertension or related complications (Abi et al. , 2007). The use of the beta-blockers would also be accompanied by any necessary procedures to deal with the occurrence of the CHF condition such as the use of intravenous diuretic therapy as an outpatient (Ryder et al. , 2008). An additional step would be the education of the patient on the reasons why the lifestyle changes that affect hypertension such as regular exercising, cutting down on smoking and partaking of alcohol as well as performing regular physical exercises would help alleviate their situation.
Weight reduction is also another lifestyle change that would positively impact the clients’ lives as well ensuring they have a balanced diet. This intervention has also been studied in terms of cost-effectiveness in numerous studies and been found to be the most cost-effective alternative when compared with other suggested interventions and medication regimes (Barry, 2002). Thus the intervention is both realistic and feasible.
The proposed solution is consistent with the community and individual culture since it empowers the client to be able to change their lifestyle in a way that conforms with the community rather than by forcing the change through a hospital stay. The intervention would thus be one that the client can carry out in their home and in their life, utilizing the knowledge imparted on them about the need for the lifestyle changes and how lack of these changes would adversely affect the impact of the medication (McDonagh et al. , 2011). The expected outcomes of this intervention would be the management of the hypertensive condition as well as the prevention of having to make an emergency visit to the hospital or clinic.
The other expected outcome is the prevention of future occurrences of CHF necessitating a visit to the emergency room or hospital admission. The outcome impact would of course be the improved quality of care of the patient, the improved quality of life that would be brought about by the adequate suppression of the hypertensive condition as well as the fact that the client has confidence that by adhering to the terms specified by the nursing provider in terms of lifestyle change and regularly taking their medication as prescribed then they can be sure of not needing to make an emergency visit to the hospital.
Abi N. I., Bouzamondo, A., Hulot, J., Dubourg, O., Le Heuzey, J., & Lechat, P. (2007, June). Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. European Heart Journal, 28, 457-462. Retrieved July 16, 2013, from ttp://eurheartj.oxfordjournals.org/content/28/4/457.full.pdf
Barry, M. (2002, June). Cost-effectiveness of beta-blocker therapy for patients with chronic severe heart failure in Ireland. IMJ, 95(6), 174-177. Retrieved July 16, 2013, from http://www.tcd.ie/Economics/msceps/courses/welfare%20economics/3.%20CEA%20beta%20blockers%20for%20heart%20failure.pdf.
McDonagh, T., Standing, M., Cleland, J., Mitchell, P., Dargie, H., Cunningham, D., & Whittaker, T. (2011).National Heart Failure Audit April 2010-March 2011. Retrieved July 16, 2013, from http://www.academia-research.com/filecache/instr/h/e/869505_heart_failure_2010_2011.pdf
Panja, M., Mondal, S., Battacharya, P., & Mondal, D. (2009).Beta-Blocker in Combination with Other Antihypertensives.SUPPLEMENT OF JAPI, 57. Retrieved July 16, 2013, from http://www.academia-research.com/filecache/instr/b/e/869505_beta_blocker_in_combination_with_other_anthiypertensives.pdf
Ryder, M., Murphy, N. F., McCaffrey, D., O'Loughlin, C., Ledwidge, M., & McDonald, K. (2008).Outpatient intravenous diuretic therapy; potential for marked reduction. European Journal of Heart Failure, 10, 267-272. Retrieved July 16, 2013, from http://www.academia-research.com/filecache/instr/o/u/869505_outpatient_intravenous_diuretic_thearpy.pdf